Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Neuroblastoma × sargramostim × Clear all

Phase

Phase 2 9 Phase 1 5 Phase 3 4 Phase 1/2 2 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myelodysplastic Syndromes 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Recurrence 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Melanoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, Neutrophilic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hodgkin Disease 1 Graft vs Host Disease 1 Dendritic Cell Sarcoma, Interdigitating 1 Congenital Abnormalities 1

Interventions

Therapeutics 3 Isotretinoin 3 Etoposide 3 Cyclophosphamide 3 Vincristine 2 Stem Cell Transplantation 2 Radiotherapy, Image-Guided 2 Radiotherapy 2 Psychiatric Rehabilitation 2 Melphalan 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Granulocyte Colony-Stimulating Factor 2 Dexamethasone 2 Cisplatin 2 Carboplatin 2 Calcium Dobesilate 2 Aprepitant 2 sargramostim 1 pegfilgrastim 1 humanized 3F8 anti-GD2 monoclonal antibody 1 hetrombopag 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 Traumeel S 1 Topotecan 1 Sugars 1 Spermine Synthase 1 Ropivacaine 1 Radiation 1 Polymerase Chain Reaction 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02786719 2020-03-12

SPRING

Baylor College of Medicine

Phase NA Completed

13 enrolled 13 charts

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡